Total Clarity Wealth Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Total Clarity Wealth Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-185	Closed	-$2.29K	–	352
2025 Q1	$2.29K	Buy	+185	New	+$2.3K	﹤0.01%	273
2022 Q3	–	Sell	-1,251	Closed	-$19K	–	1009
2022 Q2	$19K	Buy	+1,251	New	+$18.5K	0.01%	563
2022 Q1	–	Sell	-1,120	Closed	-$33K	–	952
2021 Q4	$33K	Buy	1,120 +49	+5%	+$1.4K	0.02%	475
2021 Q3	$23K	Buy	+1,071	New	+$25.9K	0.01%	538
2021 Q2	–	Sell	-1,071	Closed	-$20K	–	780
2021 Q1	$20K	Buy	+1,071	New	+$17.8K	0.01%	466

Total Clarity Wealth Management's CDMO Position: Q2 2025 in Review

Total Clarity Wealth Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q2 2025, closing a stake of 185 shares — an estimated $2.29K sold.

Total Clarity Wealth Management first reported a position in CDMO in Q1 2021 and held it in 5 quarters. The position peaked at $33K in Q4 2021. 0 funds tracked by Wall St. Rank hold CDMO as of Q2 2025.

Total Clarity Wealth Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Total Clarity Wealth Management sold 185 Avid Bioservices, Inc. Common Stock shares in Q2 2025, an estimated $2.29K.
Total Clarity Wealth Management first reported a position in Avid Bioservices, Inc. Common Stock in Q1 2021 and held it in 5 quarters.
Total Clarity Wealth Management's Avid Bioservices, Inc. Common Stock position peaked at $33K in Q4 2021.
0 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q2 2025.

Based on Total Clarity Wealth Management's 13F filing for Q2 2025, filed 25 Jul 2025.